ANTHONY PERRY: Open Payments
NPI 1619976313 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 74 payments from 17 companies in 2025. Trend: 2023 $1,408 · 2024 $1,039 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 34 | $275 |
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| ABBVIE INC. | 6 | $95 |
| Novo Nordisk Inc | 6 | $92 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| PFIZER INC. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
Products named: SUBLOCADE, BREZTRI, AIRSUPRA, Ozempic, Auvelity, VRAYLAR, GEMTESA, XIFAXAN.
Industry payments across OH — which companies pay providers there.
